Apotekamo is a technology company.
Apotekamo has raised $540K across 1 funding round.
Apotekamo has raised $540K in total across 1 funding round.
Apotekamo has raised $540K in total across 1 funding round.
Apotekamo's investors include Arena Capital.
Apotekamo is a Stockholm-based online pharmacy platform originally founded in Serbia, offering over-the-counter and prescription drugs alongside digital services like order processing and payment solutions for third-party suppliers.[1][2][3] It primarily serves consumers and pharmacies in Southeast Europe, solving the problem of limited access to convenient, digital pharmaceutical marketplaces in digitally immature markets by providing a scalable e-commerce solution for medications and related services.[1][2] The company, a portfolio of Swedish venture builder EPTI, raised €2.5 million in 2022 at a €14.6 million pre-money valuation (part of $3.13 million total funding across two rounds), fueling 740% order intake growth in early 2022 and expansions like acquiring a pharmacy in Bosnia and Herzegovina.[1][2][4]
Apotekamo was founded in 2018 in Serbia as part of Swedish venture builder EPTI, with EPTI CEO and founder Arli Mujkic highlighting its launch as a niche player in a digitally underdeveloped market.[2][4] Srdjan Milic serves as CEO, leading operations amid rapid scaling; the company relocated its headquarters to Stockholm, Sweden.[1][2][4] Key early traction included a 2022 expansion into Bosnia and Herzegovina via local pharmacy acquisition, followed by a €2.5 million funding round backed by angel collective Angelgate and FC Bayern Munich sporting director Hasan Salihamidžić, who joined as a major shareholder to aid marketing.[1][2] This investment came despite market challenges, underscoring pivotal momentum with 740% order growth in H1 2022.[1][2]
Apotekamo rides the wave of e-commerce digitization in healthcare, particularly in Southeast Europe's underserved online pharmacy sector where traditional retail dominates amid low digital maturity.[2] Timing aligns with post-pandemic acceleration in telehealth and online meds delivery, bolstered by geopolitical shifts favoring regional players.[1] Market forces like rising consumer demand for convenience and EPTI's model of scaling niche startups amplify its influence, potentially disrupting legacy pharmacies while strengthening healthcare access in the Balkans.[1][2] As a bridge between Nordic venture ecosystems and emerging markets, it contributes to Europe's startup diversity by proving scalable tech in non-Western hubs.[2]
Apotekamo is poised to dominate Southeast European online pharma through funded logistics upgrades, marketing pushes, and further expansions, leveraging its 740% growth trajectory.[1][2] Trends like AI-driven personalization in healthtech and EU digital health regulations will shape its path, potentially enabling pan-European scaling as Salihamidžić envisions.[2] Its influence may evolve from regional disruptor to ecosystem enabler, empowering local suppliers via SaaS tools—watch for order volumes and new market entries as key indicators of leadership ascent.[1][2]
Apotekamo has raised $540K across 1 funding round. Most recently, it raised $540K Seed in June 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2020 | $540K Seed | Arena Capital |